<VariationArchive VariationID="1692575" VariationName="NM_001048174.2(MUTYH):c.364dup (p.Thr122fs)" VariationType="Duplication" Accession="VCV001692575" Version="2" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-05-08" DateCreated="2022-06-24" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1685015" VariationID="1692575">
      <GeneList>
        <Gene Symbol="MUTYH" FullName="mutY DNA glycosylase" GeneID="4595" HGNC_ID="HGNC:7527" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1p34.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="45329242" stop="45340440" display_start="45329242" display_stop="45340440" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="45794913" stop="45806141" display_start="45794913" display_stop="45806141" Strand="-" />
          </Location>
          <OMIM>604933</OMIM>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_001048174.2(MUTYH):c.364dup (p.Thr122fs)</Name>
      <CanonicalSPDI>NC_000001.11:45333110:T:TT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>1p34.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="45333110" stop="45333111" display_start="45333110" display_stop="45333111" variantLength="1" positionVCF="45333110" referenceAlleleVCF="G" alternateAlleleVCF="GT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="45798782" stop="45798783" display_start="45798782" display_stop="45798783" variantLength="1" positionVCF="45798782" referenceAlleleVCF="G" alternateAlleleVCF="GT" />
      </Location>
      <ProteinChange>T122fs</ProteinChange>
      <ProteinChange>T123fs</ProteinChange>
      <ProteinChange>T133fs</ProteinChange>
      <ProteinChange>T137fs</ProteinChange>
      <ProteinChange>T147fs</ProteinChange>
      <ProteinChange>T150fs</ProteinChange>
      <ProteinChange>T30fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.45798783dup" Assembly="GRCh37">
            <Expression>NC_000001.10:g.45798783dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.45333111dup" Assembly="GRCh38">
            <Expression>NC_000001.11:g.45333111dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008189.1" sequenceAccession="NG_008189" sequenceVersion="1" change="g.12360dup">
            <Expression>NG_008189.1:g.12360dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001048171.2" sequenceAccession="NM_001048171" sequenceVersion="2" change="c.364dup">
            <Expression>NM_001048171.2:c.364dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001041636.2" sequenceAccession="NP_001041636" sequenceVersion="2" change="p.Thr122fs">
            <Expression>NP_001041636.2:p.Thr122fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001048172.2" sequenceAccession="NM_001048172" sequenceVersion="2" change="c.367dup">
            <Expression>NM_001048172.2:c.367dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001041637.1" sequenceAccession="NP_001041637" sequenceVersion="1" change="p.Thr123fs">
            <Expression>NP_001041637.1:p.Thr123fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001048173.2" sequenceAccession="NM_001048173" sequenceVersion="2" change="c.364dup">
            <Expression>NM_001048173.2:c.364dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001041638.1" sequenceAccession="NP_001041638" sequenceVersion="1" change="p.Thr122fs">
            <Expression>NP_001041638.1:p.Thr122fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001048174.2" sequenceAccession="NM_001048174" sequenceVersion="2" change="c.364dup" MANESelect="true">
            <Expression>NM_001048174.2:c.364dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001041639.1" sequenceAccession="NP_001041639" sequenceVersion="1" change="p.Thr122fs">
            <Expression>NP_001041639.1:p.Thr122fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001128425.2" sequenceAccession="NM_001128425" sequenceVersion="2" change="c.448dup" MANEPlusClinical="true">
            <Expression>NM_001128425.2:c.448dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001121897.1" sequenceAccession="NP_001121897" sequenceVersion="1" change="p.Thr150fs">
            <Expression>NP_001121897.1:p.Thr150fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001293190.2" sequenceAccession="NM_001293190" sequenceVersion="2" change="c.409dup">
            <Expression>NM_001293190.2:c.409dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001280119.1" sequenceAccession="NP_001280119" sequenceVersion="1" change="p.Thr137fs">
            <Expression>NP_001280119.1:p.Thr137fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001293191.2" sequenceAccession="NM_001293191" sequenceVersion="2" change="c.397dup">
            <Expression>NM_001293191.2:c.397dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001280120.1" sequenceAccession="NP_001280120" sequenceVersion="1" change="p.Thr133fs">
            <Expression>NP_001280120.1:p.Thr133fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001293192.2" sequenceAccession="NM_001293192" sequenceVersion="2" change="c.88dup">
            <Expression>NM_001293192.2:c.88dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001280121.1" sequenceAccession="NP_001280121" sequenceVersion="1" change="p.Thr30fs">
            <Expression>NP_001280121.1:p.Thr30fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001293195.2" sequenceAccession="NM_001293195" sequenceVersion="2" change="c.364dup">
            <Expression>NM_001293195.2:c.364dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001280124.1" sequenceAccession="NP_001280124" sequenceVersion="1" change="p.Thr122fs">
            <Expression>NP_001280124.1:p.Thr122fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001293196.2" sequenceAccession="NM_001293196" sequenceVersion="2" change="c.88dup">
            <Expression>NM_001293196.2:c.88dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001280125.1" sequenceAccession="NP_001280125" sequenceVersion="1" change="p.Thr30fs">
            <Expression>NP_001280125.1:p.Thr30fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_012222.3" sequenceAccession="NM_012222" sequenceVersion="3" change="c.439dup">
            <Expression>NM_012222.3:c.439dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_036354.1" sequenceAccession="NP_036354" sequenceVersion="1" change="p.Thr147fs">
            <Expression>NP_036354.1:p.Thr147fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_146882.2" sequenceAccession="NR_146882" sequenceVersion="2" change="n.592dup">
            <Expression>NR_146882.2:n.592dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001350651.2" sequenceAccession="NM_001350651" sequenceVersion="2" change="c.34-152dup">
            <Expression>NM_001350651.2:c.34-152dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001350650.2" sequenceAccession="NM_001350650" sequenceVersion="2" change="c.34-152dup">
            <Expression>NM_001350650.2:c.34-152dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_220" sequenceAccession="LRG_220">
            <Expression>LRG_220:g.12360dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_220t1" sequenceAccession="LRG_220t1">
            <Expression>LRG_220t1:c.448dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2149164805" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001048174.2(MUTYH):c.364dup (p.Thr122fs) AND Hereditary cancer-predisposing syndrome" Accession="RCV002257260" Version="2">
        <ClassifiedConditionList TraitSetID="13598">
          <ClassifiedCondition DB="MedGen" ID="C0027672">Hereditary cancer-predisposing syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-12-05" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001048174.2(MUTYH):c.364dup (p.Thr122fs) AND Familial adenomatous polyposis 2" Accession="RCV003505197" Version="1">
        <ClassifiedConditionList TraitSetID="1473">
          <ClassifiedCondition DB="MedGen" ID="C3272841">Familial adenomatous polyposis 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-09-27" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-09-27" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2022-06-24" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">18534194</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20663686</ID>
        </Citation>
        <DescriptionHistory Dated="2024-02-11">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="1473" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1532" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">COLORECTAL ADENOMATOUS POLYPOSIS, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="608456" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ADENOMAS, MULTIPLE COLORECTAL, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="608456" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUTYH-associated polyposis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">FAP type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Adenomas, multiple colorectal</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUTYH-related attenuated familial adenomatous polyposis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Familial adenomatous polyposis 2</ElementValue>
                <XRef ID="MONDO:0012041" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MYH-associated polyposis</ElementValue>
                <Citation Type="review" Abbrev="Lindor, 2011">
                  <ID Source="PubMed">21325953</ID>
                </Citation>
                <XRef ID="MYH-associated+polyposis/8937" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MAP</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">FAP2</ElementValue>
                <XRef Type="MIM" ID="608456" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">MUTYH polyposis (also referred to as MUTYH-associated polyposis, or MAP) is characterized by a greatly increased lifetime risk of colorectal cancer (CRC). Although typically associated with ten to a few hundred colonic adenomatous polyps, CRC develops in some individuals in the absence of polyposis. Serrated adenomas, hyperplastic/sessile serrated polyps, and mixed (hyperplastic and adenomatous) polyps can also occur. Duodenal adenomas are common, with an increased risk of duodenal cancer. The risk for malignancies of the ovary and bladder is also increased, and there is some evidence of an increased risk for breast and endometrial cancer. Additional reported features include thyroid nodules, benign adrenal lesions, jawbone cysts, and congenital hypertrophy of the retinal pigment epithelium.</Attribute>
                <XRef ID="NBK107219" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10805" />
                <XRef ID="10805" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2010">
                <ID Source="pmc">2987420</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23035301</ID>
                <ID Source="BookShelf">NBK107219</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO/ESMO, 2015">
                <ID Source="PubMed">25452455</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2014">
                <ID Source="PubMed">24310308</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACG, 2015">
                <ID Source="PubMed">25645574</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Genetics of Colorectal Cancer">
                <ID Source="PubMed">26389505</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2019">
                <URL>https://www.acmg.net/ACMG/UploadedPDFS/PDFDocuments/Familial-Adenomatous-Polyposis-ACT-Sheet.aspx</URL>
                <CitationText>American College of Medical Genetics and Genomics, Genomic Testing (Secondary Findings) ACT Sheet, APC Pathogenic Variants (Familial Adenomatous Polyposis [FAP]), 2019</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2022">
                <URL>https://www.nice.org.uk/guidance/cg118</URL>
                <CitationText>UK NICE Clinical Guideline CG118, Colorectal cancer prevention: colonoscopic surveillance in adults with ulcerative colitis, Crohn's disease or adenomas, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2021">
                <URL>https://www.nice.org.uk/guidance/ng151</URL>
                <CitationText>UK NICE Guideline NG151, Colorectal cancer, 2021</CitationText>
              </Citation>
              <XRef ID="220460" DB="Orphanet" />
              <XRef ID="247798" DB="Orphanet" />
              <XRef ID="C3272841" DB="MedGen" />
              <XRef ID="MONDO:0012041" DB="MONDO" />
              <XRef Type="MIM" ID="608456" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="13598" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18746" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hereditary cancer-predisposing syndrome</ElementValue>
                <XRef ID="699346009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary Cancer Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tumor predisposition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cancer predisposition</ElementValue>
                <XRef ID="Hereditary+Cancer/3345" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary neoplastic syndrome</ElementValue>
                <XRef ID="MONDO:0015356" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Neoplastic Syndromes, Hereditary</ElementValue>
                <XRef ID="D009386" DB="MeSH" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="19921" />
                <XRef ID="19921" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <Citation Type="general" Abbrev="IARC, 2008">
                <ID Source="pmc">3075918</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <XRef ID="140162" DB="Orphanet" />
              <XRef ID="C0027672" DB="MedGen" />
              <XRef ID="D009386" DB="MeSH" />
              <XRef ID="MONDO:0015356" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4955387" SubmissionDate="2022-04-25" DateLastUpdated="2022-06-24" DateCreated="2022-06-24">
        <ClinVarSubmissionID localKey="NM_001128425.1:c.448dupA|MedGen:C0027672" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002532291" DateUpdated="2022-06-24" DateCreated="2022-06-24" Type="SCV" Version="1" SubmitterName="Sema4, Sema4" OrgID="500057" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-12-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Sema4 Curation Guidelines</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/cy0kpury/sema4_variant_curation_guidelines-clinvar_april_2022.docx</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MUTYH" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001128425.1:c.448dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0027672" Type="CUI" />
          </Trait>
        </TraitSet>
        <Comment>To the best of our knowledge, the MUTYH c.448dupA (p.T150NfsX103) variant has not been reported in individuals with MUTYH-related disease. This variant causes a frameshift at amino acid 150 that results in premature termination 103 amino acids downstream. At this location, this is predicted to cause nonsense-mediated decay and result in an absent protein (loss of function). This variant is not reported in the population database Genome Aggregation Database (http://gnomad.broadinstitute.org, PMID: 32461654). This variant has not been reported in ClinVar. Based on the current evidence available, this variant is interpreted as likely pathogenic.</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB11360768</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8013678" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="28015260|MedGen:C1837991" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004328849" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-09-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">18534194</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20663686</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Thr150Asnfs*103) in the MUTYH gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MUTYH are known to be pathogenic (PMID: 18534194, 20663686). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with MUTYH-related conditions. ClinVar contains an entry for this variant (Variation ID: 1692575). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MUTYH" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.45798782_45798783insT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1837991" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8013678" TraitType="Disease" MappingType="XRef" MappingValue="C1837991" MappingRef="MedGen">
        <MedGen CUI="C3272841" Name="Familial adenomatous polyposis 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4955387" TraitType="Disease" MappingType="XRef" MappingValue="C0027672" MappingRef="MedGen">
        <MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

